Authority X said it was supply constriction due to RMA restriction. I am sure they did.
It's surprising how often this is offered as a received truth.
This is why I don’t think supply-side solutions are going to do much – the supply-side solutions are couched in terms of supplying the demand from local people, but we have no idea how big the supply would need to grow to deal with the demand from sources invisible to the New Zealand economy.
Totally agree. We also have no idea how this demand could change over time. It could treble over a year due to some policy change in any one of the very large countries in the world.
Yes, this occurred to me after David posted the first of this stuff in comments on earlier posts: what nature of demand are we even planning for?
it treats all input fields as potential dogging sites.
I see what you did there.
Anyway, Phil Clairmont was all over this decades ago…
So this is what porn images look like through mostly animal-trained networks; what I haven’t seen yet is a porn-trained network looking at non-porn pics. Cocks everywhere!
Shit, I hadn't thought of that. That would be even weirder ...
Tiger (original pic by Ali Little) in one of the less dog-prone models.
Gee, that's nice.
And yes, people are Deep Dreaming videos ...
That’s okay! It’s only “a little bit longer”.
If we’ve been rolled on re-patenting, I’m told it’s an additional seven years that Pharmac can’t access a generic.
My understanding is that trade agreements don’t have to be ratified by Parliament. So talk of votes and how they stack up is moot.
You are correct.
But Parliament would have to pass changes likely to be required to existing legislation, such as the Copyright Act.
NB: From that link above, Steven Joyce dodging a Parliamentary question on Pharmac losing access to generics, two years ago. They knew it was coming.
They have known this all along. Longer patent periods mean more NZ Health funding going into big pharma’s pockets. That means less for everything else if government increases its subsidy, or higher user charges if it doesn’t.
Or new drugs don't get funded because the budget has been eroded by Pharmac's loss of access to generics.
Major case in point: the new anti-virals that could basically cure every case of Hepatitis C in New Zealand. That's 50,000 people condemned to chronic disease and death.